Marcelo C. Shibata

3.3k total citations · 2 hit papers
20 papers, 2.1k citations indexed

About

Marcelo C. Shibata is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Geriatrics and Gerontology. According to data from OpenAlex, Marcelo C. Shibata has authored 20 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Geriatrics and Gerontology. Recurrent topics in Marcelo C. Shibata's work include Heart Failure Treatment and Management (11 papers), Cardiovascular Function and Risk Factors (4 papers) and Blood Pressure and Hypertension Studies (4 papers). Marcelo C. Shibata is often cited by papers focused on Heart Failure Treatment and Management (11 papers), Cardiovascular Function and Risk Factors (4 papers) and Blood Pressure and Hypertension Studies (4 papers). Marcelo C. Shibata collaborates with scholars based in Canada, United Kingdom and Italy. Marcelo C. Shibata's co-authors include Marcus Flather, Andrew J.S. Coats, Dirk J. van Veldhuisen, Alain Cohen‐Solal, Stefan D. Anker, Roberto Ferrari, Jiřı́ Toman, Alexander Parkhomenko, Jordi Soler‐Soler and Michael Böhm and has published in prestigious journals such as The Lancet, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

Marcelo C. Shibata

19 papers receiving 2.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)

2005 1.1k citations Marcus Flather, Marcelo C. Shibata et al. European Heart Journal profile →
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis

2014 363 citations Dipak Kotecha, Jane Holmes et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marcelo C. Shibata Canada	13	1.7k	256	168	151	134	20	2.1k
Pieter A. de Graeff Netherlands	24	1.3k 0.7×	350 1.4×	199 1.2×	143 0.9×	183 1.4×	63	2.1k
Annette Champion United States	14	1.4k 0.8×	321 1.3×	239 1.4×	175 1.2×	91 0.7×	23	1.7k
Aud Høieggen Norway	20	923 0.5×	375 1.5×	212 1.3×	163 1.1×	100 0.7×	78	1.6k
Carlos Escobar Spain	22	1.4k 0.8×	404 1.6×	279 1.7×	158 1.0×	64 0.5×	199	2.0k
Franz H. Messerli United States	22	1.1k 0.6×	303 1.2×	333 2.0×	63 0.4×	117 0.9×	53	1.4k
Michael Koren United States	12	1.3k 0.8×	150 0.6×	236 1.4×	60 0.4×	137 1.0×	23	1.6k
Henry Krum Australia	15	749 0.4×	166 0.6×	162 1.0×	91 0.6×	80 0.6×	35	1.2k
David H.G. Smith United States	26	1.3k 0.7×	522 2.0×	364 2.2×	227 1.5×	77 0.6×	78	1.8k
Angela L. Brown United States	18	725 0.4×	212 0.8×	117 0.7×	106 0.7×	65 0.5×	35	1.4k
Qi‐Fang Huang China	23	844 0.5×	158 0.6×	241 1.4×	176 1.2×	138 1.0×	100	1.5k

Countries citing papers authored by Marcelo C. Shibata

Since Specialization

Citations

This map shows the geographic impact of Marcelo C. Shibata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcelo C. Shibata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcelo C. Shibata more than expected).

Fields of papers citing papers by Marcelo C. Shibata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcelo C. Shibata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcelo C. Shibata. The network helps show where Marcelo C. Shibata may publish in the future.

Co-authorship network of co-authors of Marcelo C. Shibata

This figure shows the co-authorship network connecting the top 25 collaborators of Marcelo C. Shibata. A scholar is included among the top collaborators of Marcelo C. Shibata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcelo C. Shibata. Marcelo C. Shibata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shibata, Marcelo C., et al.. (2020). Six-minute walk test: prognostic value and effects of nebivolol versus placebo in elderly patients with heart failure from the SENIORS trial. Clinical Research in Cardiology. 110(8). 1193–1201. 3 indexed citations

Tsuyuki, Ross T., Evan Lockwood, Marcelo C. Shibata, et al.. (2019). A Randomized Trial of Video-based Education in Patients With Heart Failure: The Congestive Heart Failure Outreach Program of Education (COPE). CJC Open. 1(2). 62–68. 4 indexed citations

Kotecha, Dipak, Jane Holmes, Henry Krum, et al.. (2014). Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. The Lancet. 384(9961). 2235–2243. 363 indexed citations breakdown →

Shibata, Marcelo C.. (2013). What is wrong with meta-analysis? The importance of clinical heterogeneity in myocardial regeneration research. International Journal of Clinical Practice. 67(11). 1081–1085. 4 indexed citations

Manzano, Luís, Daphne Babalis, Sy Ha, et al.. (2011). Predictors of Clinical Outcomes in Elderly Patients with Heart Failure. European Journal of Heart Failure. 13(5). 528–536. 94 indexed citations

Shibata, Marcelo C., Hernando León, Trish Chatterley, Marlene Dorgan, & Ben Vandermeer. (2010). Do Calcium Channel Blockers Increase the Diagnosis of Heart Failure in Patients With Hypertension?. The American Journal of Cardiology. 106(2). 228–235. 12 indexed citations

Eurich, Dean T., Ross T. Tsuyuki, Sumit R. Majumdar, et al.. (2009). Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality. Trials. 10(1). 12–12. 42 indexed citations

Shibata, Marcelo C., Ross T. Tsuyuki, & Natasha Wiebe. (2008). The effects of angiotensin-receptor blockers on mortality and morbidity in heart failure: a systematic review. International Journal of Clinical Practice. 62(9). 1397–1402. 15 indexed citations

León, Hernando, Marcelo C. Shibata, Soori Sivakumaran, et al.. (2008). Effect of fish oil on arrhythmias and mortality: systematic review. BMJ. 337(dec23 2). a2931–a2931. 161 indexed citations

10.

Shibata, Marcelo C., et al.. (2005). Utilization of Evidence-Based Therapies for Heart Failure in the Institutionalized Elderly. European Journal of Heart Failure. 7(7). 1122–1125. 13 indexed citations

11.

Bakhai, Ameet, J Collinson, Marcus Flather, et al.. (2005). Diabetic patients with acute coronary syndromes in the UK: high risk and under treated. Results from the prospective registry of acute ischaemic syndromes in the UK (PRAIS-UK). International Journal of Cardiology. 100(1). 79–84. 22 indexed citations

12.

Flather, Marcus, Marcelo C. Shibata, Andrew J.S. Coats, et al.. (2005). Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). European Heart Journal. 26(3). 215–225. 1092 indexed citations breakdown →

13.

Shibata, Marcelo C., Carolyn Nilsson, Marilou Hervas‐Malo, Philip Jacobs, & Ross T. Tsuyuki. (2005). Economic implications of treatment guidelines for congestive heart failure.. PubMed. 21(14). 1301–6. 8 indexed citations

14.

Tsuyuki, Ross T., Marcelo C. Shibata, Carolyn Nilsson, & Marilou Hervas‐Malo. (2003). Contemporary burden of illness of congestive heart failure in Canada.. PubMed. 19(4). 436–8. 53 indexed citations

15.

Shibata, Marcelo C., Marcus Flather, Michael Böhm, et al.. (2002). Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS).. International Journal of Cardiology. 86(1). 77–85. 46 indexed citations

16.

Shibata, Marcelo C., Belinda Lees, Peter Collins, et al.. (2001). Prevention of cardiovascular disease in women: evidence for the use of hormone replacement therapy. The Journal of the British Menopause Society. 7(1). 33–37.

17.

Shibata, Marcelo C., Marcus Flather, Diego Pérez de Arenaza, Duolao Wang, & J.Conor O’Shea. (2001). Potential impact of socioeconomic differences on clinical outcomes in international clinical trials. American Heart Journal. 141(6). 1019–1024. 13 indexed citations

18.

Shibata, Marcelo C., Marcus Flather, & Duolao Wang. (2001). Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure. European Journal of Heart Failure. 3(3). 351–357. 110 indexed citations

19.

Shibata, Marcelo C. & Toshio Moritani. (1991). The Mechanism of Electromyographic Silent Periods Preceding a Ballistic Voluntary Planter Flexion.. The Annals of physiological anthropology. 10(4). 211–218. 2 indexed citations

20.

Hirata, Yuichiro, et al.. (1968). Experimental Studies on the Development of Kernicterus. Neonatology. 12(5-6). 371–377. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact